Page 1429 - Clinical Small Animal Internal Medicine

155 Mast Cell Neoplasia 1367

Further Reading
VetBooks.ir Blackwood L, Murphy S, Buracco P, et al. European kinase inhibitor, for the treatment of dogs with

consensus document on mast cell tumors in dogs and
cats. Vet Compar Oncol 2012; 10(3): e1–e29. recurrent (either local or distant) mast cell tumor
following surgical excision. Clin Cancer Res 2009; 15:
Cooper M, Tsai X, Bennett P. Combination CCNU and 3856–65.
vinblastine chemotherapy for canine mast cell tumors: Rassnick KM, Bailey D, Russell D, et al. A phase II study to
57 cases. Vet Compar Oncol 2009; 7(3): 196–206. evaluate the toxicity and efficacy of alternating CCNU
Kiupel M, Webster J, Bailey K, et al. Proposal of a 2‐tier and high‐dose vinblastine and prednisone (CVP) for
histologic grading system for canine cutaneous mast cell treatment of dogs with high‐grade, metastatic or
tumors to more accurately predict biological behavior. nonresectable mast cell tumors. Vet Compar Oncol
Vet Pathol 2011; 48(1): 147–55. 2010; 8(2): 138–52.
London C, Malpas P, Wood‐Follis S, et al. Multi‐center, Warland J, Amores‐Fuster I, Newbury W, et al. The utility
placebo controlled, double‐blind, randomized study of of staging canine mast cell tumours. Vet Compar Oncol
oral toceranib phosphate (SU11654), a receptor tyrosine 2014; 12(4): 287–98.